MYO6 and renal cell carcinoma: In univariate survival analysis, the patients with RCCs expressing cytoplasmic myosin VI had a tendency for lower RCC-specific survival, but this was not significant (p = 0.27 for ten-year RCC-specific survival) (Figure 1, Table 4).